(Q36359687)

13 August 2017

1 reference

title

Intravenous immunoglobulin therapy in vasculitis: speculation or evidence? (English)

1 reference

13 August 2017

Peer Malte Aries

1

1 reference

13 August 2017

Bernhard Hellmich

series ordinal

2

1 reference

13 August 2017

Wolfgang Ludwig Gross

series ordinal

3

1 reference

13 August 2017

publication date

1 December 2005

1 reference

Clinical Reviews in Allergy & Immunology

13 August 2017

published in

1 reference

13 August 2017

volume

29

1 reference

13 August 2017

issue

3

1 reference

13 August 2017

page(s)

237-245

1 reference

https://scigraph.springernature.com/pub.10.1385/criai:29:3:237

13 August 2017

exact match

0 references

cites work

Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity

1 reference

12 December 2020

Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children

1 reference

12 December 2020

The B cell superantigen-like interaction of intravenous immunoglobin (IVIG) with Fab fragments of V(H) 3-23 and 3-30/3-30.5 germline gene origin cloned from a patient with Kawasaki disease is enhanced after IVIG therapy

1 reference

12 December 2020

Pooled intravenous immunoglobulin in the management of systemic vasculitis

1 reference

12 December 2020

The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment.

1 reference

12 December 2020

Antigenic recognition by intravenous gamma-globulin of selected bacteria isolated from throats of patients with Kawasaki syndrome

1 reference

12 December 2020

Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis

1 reference

12 December 2020

1 reference

12 December 2020

High-dose intravenous gammaglobulin for Kawasaki disease

1 reference

12 December 2020

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

1 reference

12 December 2020

Marked improvement of Churg-Strauss vasculitis with intravenous gammaglobulins

1 reference

12 December 2020

Selective expansion of T cells expressing V beta 2 in toxic shock syndrome

1 reference

12 December 2020

Intravenous immunoglobulin and the kidney--a two-edged sword

1 reference

12 December 2020

Factors relating to the cardiac sequelae of Kawasaki disease one month after initial onset

1 reference

12 December 2020

Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome

1 reference

12 December 2020

Intravenous immunoglobulin as sole therapy for systemic vasculitis

1 reference

12 December 2020

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

1 reference

12 December 2020

Treatment of systemic vasculitis with pooled intravenous immunoglobulin

1 reference

12 December 2020

Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use.

1 reference

12 December 2020

Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]

1 reference

12 December 2020

IL-1 beta production by human polymorphonuclear leucocytes stimulated by anti-neutrophil cytoplasmic autoantibodies: relevance to systemic vasculitis

1 reference

12 December 2020

The staphylococcal enterotoxins and their relatives.

1 reference

12 December 2020

From black magic to science: understanding the rationale for the use of intravenous immunoglobulin to treat inflammatory myopathies

1 reference

12 December 2020

Intravenous immunoglobulin for the treatment of Kawasaki disease in children

1 reference

12 December 2020

1 reference

12 December 2020

Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B.

1 reference

12 December 2020

Intravenous immunoglobulin in Henoch-Schönlein purpura

1 reference

12 December 2020

Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose

1 reference

12 December 2020

Early treatment with intravenous immunoglobulin in patients with Kawasaki disease

1 reference

12 December 2020

Treatment of parvovirus B19-associated polyarteritis nodosa with intravenous immune globulin

1 reference

12 December 2020

Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin

1 reference

12 December 2020

Kawasaki syndrome: review of new epidemiologic and laboratory developments

1 reference

12 December 2020

Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin

1 reference

12 December 2020

Modulation of complement-mediated immune damage by intravenous immune globulin

1 reference

12 December 2020

ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin

1 reference

12 December 2020

A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome

1 reference

12 December 2020

Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease

1 reference

12 December 2020

The immunopathogenesis and management of Kawasaki syndrome

1 reference

12 December 2020

The acute phase nature of interleukin 6: studies in Kawasaki disease and other febrile illnesses.

1 reference

12 December 2020

Immunoregulatory abnormalities in mucocutaneous lymph node syndrome

1 reference

12 December 2020

Initial intravenous gammaglobulin treatment failure in Kawasaki disease

1 reference

12 December 2020

Update on the European Vasculitis Study Group trials

1 reference

12 December 2020

Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group

1 reference

12 December 2020

High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch-Schönlein purpura.

1 reference

12 December 2020

Intravenous immunoglobulin (IVIg) therapy in MPO-ANCA related polyangiitis with rapidly progressive glomerulonephritis in Japan

1 reference

12 December 2020

Anti-idiotypic antibody D12 and superantigen SPA both interact with human VH3-encoded antibodies on the external face of the heavy chain involving FR1, CDR2 and FR3

1 reference

12 December 2020

Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease

1 reference

12 December 2020

Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease

1 reference

12 December 2020

Renal toxicity of intravenous immunoglobulin

1 reference

12 December 2020

Asthma and vasculitis. Response to intravenous immunoglobulins

1 reference

12 December 2020

Kawasaki disease and toxic shock syndrome--at last the etiology is clear?

1 reference

12 December 2020

Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy

1 reference

12 December 2020

Identifiers

DOI

10.1385/CRIAI:29:3:237

1 reference

Dimensions Publication ID

13 August 2017

1002038023

0 references

1 reference